Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Anthony L. Young
Observed names:
Anthony L Young,
Anthony Young
Institution:
Pfizer (United States)
Observed institution:
Pfizer (United States)
OpenAlex ID:
A5024259840
Fluticasone and budesonide nanosuspensions for pulmonary delivery: Preparation, characterization, and pharmacokinetic studies
2008
·
Jerry Z. Yang
, Anthony L. Young
, et al.
·
Journal of Pharmaceutical Sciences
·
95
Impact of Annealing and Controlled Ice Nucleation on Properties of A Lyophilized 50 mg/ml MAB Formulation
2022
·
Jijun Wang
, James A. Searles
, et al.
·
Journal of Pharmaceutical Sciences
·
18
PDF
Ex Situ and In Situ Characterization of Vaccine Suspensions in Pre-Filled Syringes
2017
·
Lavinia M. Lewis
, Jianxin Guo
, et al.
·
Journal of Pharmaceutical Sciences
·
11
Premarket notifications of new dietary ingredients--a ten-year review.
2004
·
Michael McGuffin
, Anthony L Young
·
PubMed
·
10
Dietary supplements
2018
·
Anthony L. Young
, James William Woodlee
, et al.
·
Elsevier eBooks
·
2
Formulation and Stability
2016
·
Kouhei Tsumoto
, Anthony Young
, et al.
·
Wiley eBooks
·
2
Dietary supplements
2025
·
Anthony Young
, James Woodlee
, et al.
·
Elsevier eBooks
·
1
Current case developments: Defense of CERCLA and toxic tort hazardous‐waste site claims: Love Canal, revisited
1998
·
Steven K. Yablonsk
, Anthony L. Young
, et al.
·
Environmental Claims Journal
Product Liability Considerations in Prescription Drug Labeling
1993
·
Anthony L. Young
, Norman L. Rave
·
Drug Information Journal
Show more works
View as search
Works count:
11
Citation count:
140
H-index:
4
I10-index:
4
Year
Topic
Type